{
    "Trade/Device Name(s)": [
        "Poly-Chem 90 Direct HDL-Cholesterol",
        "Poly-Chem 90 Direct LDL-Cholesterol",
        "Poly-Chem 90 Cholesterol",
        "Poly-Chem 90 Triglycerides tests"
    ],
    "Submitter Information": "Polymedco, Inc.",
    "510(k) Number": "K100550",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LBS",
        "MRR",
        "CHH",
        "CDT"
    ],
    "Summary Letter Date": "September 14, 2010",
    "Summary Letter Received Date": "September 15, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1475"
    ],
    "Regulation Name(s)": [
        "Lipoprotein test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "HDL Cholesterol",
        "LDL Cholesterol",
        "Cholesterol",
        "Triglycerides"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Poly-Chem 90 analyzer"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Poly-Chem 90 system tests for HDL-Cholesterol, LDL-Cholesterol, Cholesterol, and Triglycerides on human serum using the Poly-Chem 90 analyzer",
    "Indications for Use Summary": "Intended for quantitative measurement of HDL Cholesterol, LDL Cholesterol, Cholesterol, and Triglycerides in human serum to aid diagnosis and treatment of lipid disorders, atherosclerosis, liver and renal diseases, and for assessment of cardiovascular disease risk",
    "fda_folder": "Clinical Chemistry"
}